Manchester Financial Inc Acadia Pharmaceuticals Inc Transaction History

Manchester Financial Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$19.4 - $27.42 $11,310 - $15,985	-583 Closed	0 $0
Q1 2021 May 03, 2021	BUY	$25.02 - $54.99 $2,702 - $5,938	108 Added 22.74%	583 $15,000
Q4 2019 Jan 17, 2020	BUY	$36.21 - $51.4 $17,199 - $24,415	475 New	475 $20,000
Q3 2019 Oct 09, 2019	SELL	$22.22 - $44.01 $10,554 - $20,904	-475 Closed	0 $0
Q2 2019 Jul 23, 2019	BUY	$23.32 - $28.12 $11,077 - $13,357	475 New	475 $13,000

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.65B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Manchester Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Manchester Financial Inc with notifications on news.